Interest in anti-PF4 disorders rekindled when first cases of vaccine-induced immune thrombocytopenia and thrombosis (VITT) occurred during the worldwide COVID-19 vaccination campaign. The gene discussed is PF4; the disease is autoimmune thrombocytopenic purpura.